COVID-19 now tends to see spikes during cold and flu seasons. Most vaccinated people who contract COVID-19 are not at risk ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache ...

with the following symptoms commonly reported in connection to COVID-19: Earlier reports had centered on potential gastrointestinal symptoms related to the virus. Dr. Katelyn Jetelina ...

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...

It tends to cause cold-like symptoms, which can make it difficult to tell it apart from other respiratory viruses, such as the flu or COVID-19. The virus isn’t usually a cause of concern in ...

COVID-19 symptoms and flu symptoms are very similar, insofar as they cannot be diagnosed by symptoms alone, with testing required to distinguish one from the other. "Compared with flu, COVID-19 ...

Rand Paul (R-KY) on Monday announced that his committee subpoenaed 14 federal agencies from the exiting Biden-Harris administration in a sweeping investigation into the origins of COVID-19 and U.S ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

The study recruited the first 1,300 patients with neurological symptoms of Long COVID at the Northwestern Medicine Neuro COVID-19 Clinic between May 2020 and March 2023. Of the 1,300 participants ...